Please use this identifier to cite or link to this item:
Title: Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practice.
Authors: White, Helena A .
Miller, R. F.
Pozniak, A. L.
Lipman, M. C.
Stephenson, Iain
Wiselka, Martin J.
Pareek, Manish
First Published: 14-Oct-2016
Publisher: BMJ Publishing Group, British Thoracic Society (BTS)
Citation: Thorax, 2016
Abstract: Latent TB infection (LTBI) screening and treatment in HIV-positive individuals in the UK is advocated by the British HIV Association (BHIVA) and National Institute for Health and Care Excellence (NICE), although each recommends differing strategies. We undertook an evaluation of UK practice, relating the responses to the local HIV/TB disease burden. 162 of 188 (86%) UK geographical areas responded; only 93/162 (57.4%) offer LTBI testing with considerable heterogeneity in practice, and no difference in HIV/TB burden between areas offering testing and those who do not. Only 33/93 (35.5%) and 6/93 (6.5%) reported full compliance with BHIVA and NICE guidance respectively. A uniform national guideline is required.
DOI Link: 10.1136/thoraxjnl-2016-209063
ISSN: 0040-6376
eISSN: 1468-3296
Version: Post-print
Status: Peer-reviewed
Type: Journal Article
Rights: Creative Commons “Attribution Non-Commercial No Derivatives” licence CC BY-NC-ND, further details of which can be found via the following link: Archived with reference to SHERPA/RoMEO and publisher website.
Description: Additional material is published online only. To view please visit the journal online ( 1136/thoraxjnl-2016-209063)
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
File Description SizeFormat 
LTBIHIVscreeningmanuscript260816 (1).pdfPost-review (final submitted author manuscript)476.07 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.